RIPASA Score Calculator – Acute Appendicitis Diagnostic Assessment

Clinical calculation support · Verify results before clinical use

Clinical Assessment

Enter the patient's demographic, symptom, examination, and laboratory findings.

—Total score
01

Age

Enter age in completed years.

1 or 0.5 point
≤40 years: 1 point · >40 years: 0.5 point
02

Sex

1 or 0.5 point
r1

Right iliac fossa (RIF) pain

Pain localized to the right iliac fossa.

+0.5 points
r2

Migration of pain to the RIF

Pain initially elsewhere and subsequently migrating to the right iliac fossa.

+0.5 points
r3

Nausea or vomiting

Presence of nausea and/or vomiting.

+1 point
r4

Anorexia

Reduced or absent appetite.

+1 point
07

Duration of symptoms

Enter duration from symptom onset to assessment.

1 or 0.5 point
≤48 hours: 1 point · >48 hours: 0.5 point
r8

RIF tenderness

Localized tenderness in the right iliac fossa.

+1 point
r9

Guarding

Abdominal guarding on examination.

+2 points
r10

Rebound tenderness

Rebound tenderness on examination.

+1 point
r11

Rovsing’s sign

Right lower quadrant pain elicited by left-sided colonic palpation.

+2 points
r12

Fever

Fever documented on clinical assessment.

+1 point
r13

Raised white blood cell count

Use the laboratory’s applicable upper reference limit.

+1 point
r14

Negative urinalysis

Select yes when urinalysis is negative according to the local assessment protocol.

+1 point
15

Foreign national registration identity card

Included in the original Brunei/Singapore derivation cohort as a local demographic/administrative variable. It may not be applicable outside that setting.

+1 point if present

For patients outside the original setting, select “Not applicable”. This preserves the original item transparently but means the full derivation score may not be directly transportable.

—RIPASA
Diagnostic threshold (7.5)
Complete all required fields
Select all clinical findings and enter age and symptom duration to calculate the score.
Clinical interpretationThe RIPASA score is an adjunct to clinical assessment. It does not establish or exclude appendicitis on its own.

A score ≥7.5 is the commonly reported positive threshold. Diagnostic performance varies across populations and study settings; use clinical assessment, laboratory findings, imaging, and surgical review as appropriate.

About the RIPASA Score

The Raja Isteri Pengiran Anak Saleha Appendicitis (RIPASA) score is a clinical scoring system developed to support the assessment of suspected acute appendicitis. Its original derivation study used 15 parameters in patients undergoing emergency appendicectomy.

Scoring components

ParameterCriterionPoints
Age≤40 years / >40 years1 / 0.5
SexMale / Female1 / 0.5
RIF painPresent0.5
Migration of painTo RIF0.5
Nausea or vomitingPresent1
AnorexiaPresent1
Symptom duration≤48 h / >48 h1 / 0.5
RIF tendernessPresent1
GuardingPresent2
Rebound tendernessPresent1
Rovsing’s signPresent2
FeverPresent1
Raised WBC countAbove local reference range1
Negative urinalysisPresent1
Foreign national registration identity cardPresent (original setting-specific variable)1

Interpretation

<7.5: Below the commonly used positive threshold. This does not rule out acute appendicitis.

≥7.5: Positive threshold associated with increased likelihood of acute appendicitis; further clinical evaluation is required.

The original study reported a threshold of 7.5. The exact handling of age 40 and symptom duration 48 hours is not explicit in the original abstract; this calculator uses ≤40 years and ≤48 hours as operational conventions consistent with a contemporary clinical summary.

Evidence and Limitations

The original score was derived retrospectively in a single regional cohort. Its performance should not be assumed to transfer unchanged to every healthcare setting.

  • The foreign national registration identity card item is specific to the original population context and is not a clinical sign. For patients outside that context, mark it “Not applicable”; interpret the resulting score cautiously.
  • Meta-analyses report high pooled sensitivity but moderate specificity, with substantial between-study heterogeneity.
  • The 2025 WSES Jerusalem guideline suggests AIR, AAS, and PAS for risk stratification; RIPASA is not among the scores named in that recommendation.
  • Fever and raised WBC are entered as documented clinical/laboratory findings. Follow local definitions and reference intervals; the original abstract does not provide a universal numeric threshold for these items.

Selected references

Chong CF, Adi MI, Thien A, et al. (2010)Development of the RIPASA score: a new appendicitis scoring system for the diagnosis of acute appendicitis. Singapore Medical Journal. 51(3):220–225. PMID: 20428744. PubMed record. No DOI listed in the PubMed record.
Favara G, Maugeri A, Barchitta M, et al. (2022)Comparison of RIPASA and ALVARADO scores for risk assessment of acute appendicitis: A systematic review and meta-analysis. PLoS ONE. 17(9):e0275427. DOI: 10.1371/journal.pone.0275427.
Clinical scores for acute appendicitis in adults: A systematic review and meta-analysis of diagnostic accuracy studies (2025)The American Journal of Surgery. 240:116123. DOI: 10.1016/j.amjsurg.2024.116123.
Podda M, Ceresoli M, De Simone B, et al. (2026)Diagnosis and Treatment of Acute Appendicitis: 2025 Edition of the World Society of Emergency Surgery Jerusalem Guidelines. JAMA Surgery. 161(3):283–295. DOI: 10.1001/jamasurg.2025.6218.
Clinical disclaimer: The RIPASA score is an adjunctive diagnostic assessment tool, not a standalone diagnostic test or a substitute for clinical judgement. A score below the threshold does not exclude appendicitis, and a score at or above the threshold does not confirm it. Consider differential diagnoses, serial examination, laboratory testing, imaging, and timely surgical consultation according to the patient's clinical condition and local protocols.